Difference between revisions of "Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x (Q10666)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Pandharipande PP, #quickstatements; #temporary_batch_1592744349395) |
(Created claim: Second Author string (P150): Shintani A, #quickstatements; #temporary_batch_1592745892439) |
||
| Property / Second Author string | |||
| + | Shintani A | ||
| Property / Second Author string: Shintani A / rank | |||
| + | Normal rank | ||
Revision as of 13:25, 21 June 2020
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Crit Care; 2020 04 28 ; 24 (1) 176
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x
|
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Crit Care; 2020 04 28 ; 24 (1) 176
|
Statements
Sedative and analgesic medications are independent risk factors in ICU patients for transitioning into delirium (English)
0 references
2004
0 references
Pandharipande PP
0 references
Shintani A
0 references
